UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063382
Receipt number R000072412
Scientific Title Intestinal mucin glycosylation and clinical relapse in ulcerative colitis in remission: a single-center prospective observational study
Date of disclosure of the study information 2026/11/01
Last modified on 2026/10/23 08:22:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intestinal mucin and relapse in patients with ulcerative colitis in remission

Acronym

Intestinal mucin and relapse in patients with ulcerative colitis in remission

Scientific Title

Intestinal mucin glycosylation and clinical relapse in ulcerative colitis in remission: a single-center prospective observational study

Scientific Title:Acronym

Intestinal mucin glycosylation and clinical relapse in ulcerative colitis in remission: a single-center prospective observational study

Region

Japan


Condition

Condition

Ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate intestinal mucin at the glycan level in the colonic mucosa of patients with ulcerative colitis in remission. To examine whether its expression predicts subsequent clinical relapse.

Basic objectives2

Others

Basic objectives -Others

Exploration of a prognostic factor for relapse risk (examining whether intestinal mucin expression predicts future disease course, rather than evaluating treatment efficacy or diagnostic performance)

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Association between intestinal mucin expression and clinical relapse in patients with ulcerative colitis in remission.

Key secondary outcomes

Difference in intestinal mucin expression between patients in remission and those with active disease
Association of endoscopic severity and endoscopic images with intestinal mucin expression
Association between changes in disease activity and intestinal mucin expression within the same patient


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 18 years or older who were diagnosed with and treated for ulcerative colitis at Kitasato University Hospital and underwent colonoscopy.

Key exclusion criteria

1. Patients who have undergone or are scheduled for surgical resection for ulcerative colitis
2. Patients with ulcerative proctitis
3. Patients who cannot attend long-term follow-up
4. Pregnant or breastfeeding women
5. Patients who do not provide informed consent

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Chika
Middle name
Last name Kusano

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0375

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

042-778-8111

Email

ckusano@kitasato-u.ac.jp


Public contact

Name of contact person

1st name Toshiki
Middle name
Last name Horii

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0375

Address

1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan

TEL

0117221110

Homepage URL


Email

horii.toshiki@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University School of Medicine and Hospital Ethics Committee

Address

1-15-1 Kitasato, Minami-ku, Sagamihara

Tel

0117221110

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 15 Day

Date of IRB

2026 Year 09 Month 16 Day

Anticipated trial start date

2026 Year 11 Month 01 Day

Last follow-up date

2031 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Single-center, prospective longitudinal study. Additional colonic mucosal biopsies for research are obtained during colonoscopy performed as part of routine clinical care. Mucin glycan expression in the intestinal mucosa is analyzed at the Department of Pathophysiological Biochemistry, Kitasato University School of Allied Health Sciences. Clinical severity, treatment, blood test results, endoscopic findings, and histological findings are collected from medical records for up to 108 weeks after colonoscopy.


Management information

Registered date

2026 Year 10 Month 23 Day

Last modified on

2026 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072412